Doubts clog sales of new Abbott pill

A new cholesterol drug from Abbott Laboratories is off to a sluggish start, spotlighting the challenges the drugmaker faces as it pursues new heart medications. Sales of Simcor — a combination of two drugs to boost "good cholesterol" while reducing the harmful kind — are expected to ...

Copyright CRAIN - Crain's
Contact Us